Literature DB >> 2296963

Gastric mucosal prostaglandin synthesis in the presence of Campylobacter pylori in patients with gastric ulcers and non-ulcer dyspepsia.

A S Taha1, P Boothman, P Holland, A McKinlay, R Upadhyay, R W Kelly, F Lee, R I Russell.   

Abstract

It is unclear how Campylobacter pylori (CP) interacts with gastric mucosal prostaglandins (PG). In a double-blind study we measured gastric PG synthesis in 22 patients with benign gastric antral ulcers (GU) and 26 with non-ulcer dyspepsis (NUD). CP status was determined by histology and bacteriology: 26 (16 GU plus 10 NUD) were CP positive, and 22 (6 GU plus 16 NUD) were CP negative. Patients with severe gastritis regardless of CP status) had significantly higher PGE2 and PGI2 values than those with mild gastritis. Severe gastritis was found in 36% of CP-negative subjects and 77% of the CP-positive patients (chi 2 = 8.64, p less than 0.01), but no significant differences in PG values were found between CP-positive or -negative patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296963

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  12 in total

1.  Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease.

Authors:  A S Taha; R I Russell
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

2.  Evidence for hypomotility in non-ulcer dyspepsia: a prospective multifactorial study.

Authors:  B Waldron; P T Cullen; R Kumar; D Smith; J Jankowski; D Hopwood; D Sutton; N Kennedy; F C Campbell
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

Review 3.  Helicobacter pylori-associated peptic ulcer disease in older patients: current management strategies.

Authors:  A Pilotto
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

4.  Serological diagnosis of Helicobacter pylori--evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs.

Authors:  A S Taha; J Reid; P Boothmann; C G Gemmell; F D Lee; R D Sturrock; R I Russell
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

5.  The association between cagA+ H. pylori infection and distal gastric cancer: a proposed model.

Authors:  Mohammed S Al-Marhoon; Sheila Nunn; Roger W Soames
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

6.  Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration.

Authors:  A S Taha; I Nakshabendi; F D Lee; R D Sturrock; R I Russell
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

7.  Duodenal histology, ulceration, and Helicobacter pylori in the presence or absence of non-steroidal anti-inflammatory drugs.

Authors:  A S Taha; S Dahill; I Nakshabendi; F D Lee; R D Sturrock; R I Russell
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

8.  Prostaglandin E2 in gastric mucosa of children with Helicobacter pylori gastritis: relation to thickness of mucus gel layer.

Authors:  G Oderda; M D'Alessandro; P Mariani; P Lionetti; M Bonamico; D Dell'Olio; N Ansaldi
Journal:  J Clin Pathol       Date:  1993-09       Impact factor: 3.411

9.  Diagnostic tests for Helicobacter pylori: comparison and influence of non-steroidal anti-inflammatory drugs.

Authors:  A S Taha; P Boothman; I Nakshabendi; J Reid; C Morran; C G Gemmell; F D Lee; R D Sturrock; R I Russell
Journal:  J Clin Pathol       Date:  1992-08       Impact factor: 3.411

10.  Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs.

Authors:  N Hudson; M Balsitis; F Filipowicz; C J Hawkey
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.